The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised $28 million in Series C funding. The funding will accelerate commercial growth of the company’s Transpara AI breast care software, which uses machine learning technology and curated databases of screening mammograms to improve early diagnosis of breast cancer. The investment will also enable further R&D and expansion of the product portfolio.
ScreenPoint was founded in 2014 as a spinoff from Radboud University Medical Center in Nijmegen, Netherlands.READ MORE